Medicare Enrolled
Dr. Gregory George, M.D.
Family Medicine - Adult · Sharon, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. George from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. George?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. George
Dr. Gregory George is a family medicine - adult specialist in Sharon, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. George performed 1,683 Medicare services across 1,124 unique beneficiaries.
Between the years covered by Open Payments, Dr. George received a total of $5,971 from 34 pharmaceutical and/or device companies across 354 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine - adult. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. George is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 18% volume in PA
$5,971 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,683
Medicare services
Top 18% in PA for family medicine - adult
1,124
Unique beneficiaries
$51
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~84 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
267 | $50 | $224 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
208 | $36 | $124 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
151 | $120 | $344 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
138 | $0 | $1 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
134 | $78 | $334 |
| Nursing facility visit, low complexity A daily follow-up visit for an existing patient in a nursing facility involving straightforward medical decision making. The visit requires at least 15 minutes of time if time is used to determine the level of care. |
119 | $51 | $207 |
| Annual depression screening | 117 | $17 | $57 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
67 | $8 | $77 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
61 | $90 | $450 |
| Hospital discharge day management, 30 minutes or less This service covers the final day of hospital care when the patient is being discharged. It includes coordination of care and instructions for the patient within a time frame of 30 minutes or less. |
61 | $60 | $221 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
59 | $37 | $136 |
| Initial nursing facility care, moderate complexity Initial care provided to a patient in a nursing facility with moderate medical decision making, taking at least 35 minutes. |
57 | $94 | $388 |
| Betamethasone steroid injection An injection containing a combination of betamethasone acetate and betamethasone sodium phosphate. |
47 | $3 | $20 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
44 | $85 | $448 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
41 | $29 | $82 |
| Nursing facility visit, established patient, straightforward A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves straightforward medical decision making and lasts at least 10 minutes. |
31 | $27 | $135 |
| Quadrivalent influenza vaccine, cell-culture derived A flu shot containing four strains of influenza virus, produced using cell culture technology rather than eggs. This formulation is free from preservatives and antibiotics. |
21 | $33 | $88 |
| Flu vaccine, quadrivalent A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection. |
20 | $74 | $183 |
| Initial nursing facility care, high complexity An initial visit by a healthcare provider to a patient in a nursing facility involving a high level of medical decision making, lasting at least 45 minutes. |
15 | $136 | $495 |
| Nursing facility visit, moderate complexity A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves moderate medical decision making and takes at least 30 minutes. |
13 | $57 | $274 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
12 | $40 | $137 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$5,971
Total received (2018-2024)
Avg $853/year across 7 years
Top 14% in PA for family medicine - adult
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
34
Companies
354
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,970 (100.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1 (0.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,317
2023
$1,433
2022
$1,294
2021
$887
2020
$215
2019
$472
2018
$353
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
GlaxoSmithKline, LLC.
$403
AstraZeneca Pharmaceuticals LP
$350
Otsuka America Pharmaceutical, Inc.
$94
Novo Nordisk Inc
$80
Lilly USA, LLC
$62
Exact Sciences Corporation
$57
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$52
Novartis Pharmaceuticals Corporation
$47
E.R. Squibb & Sons, L.L.C.
$43
Amgen Inc.
$43
PFIZER INC.
$37
Dexcom, Inc.
$18
Janssen Pharmaceuticals, Inc
$17
ABBVIE INC.
$14
Top 3 companies account for 64.4% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$1,687
AstraZeneca Pharmaceuticals LP
$806
Lilly USA, LLC
$485
ABBVIE INC.
$399
PFIZER INC.
$370
E.R. Squibb & Sons, L.L.C.
$238
Novo Nordisk Inc
$233
Janssen Pharmaceuticals, Inc
$205
Boehringer Ingelheim Pharmaceuticals, Inc.
$164
AbbVie Inc.
$146
Otsuka America Pharmaceutical, Inc.
$145
Boston Scientific Corporation
$143
Amgen Inc.
$125
Novartis Pharmaceuticals Corporation
$123
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$122
Merck Sharp & Dohme Corporation
$104
Merck Sharp & Dohme LLC
$97
Exact Sciences Corporation
$75
Amarin Pharma Inc.
$51
Allergan Inc.
$32
Lundbeck LLC
$26
Edwards Lifesciences Corporation
$24
ACADIA Pharmaceuticals Inc
$21
Neurelis, Inc.
$19
Dexcom, Inc.
$18
Evoke Pharma, Inc.
$15
Abbott Laboratories
$15
Kowa Pharmaceuticals America, Inc.
$14
Genentech USA, Inc.
$14
Collegium Pharmaceutical, Inc.
$14
Athena Bioscience, LLC
$14
Noden Pharma USA Inc
$13
SANOFI-AVENTIS U.S. LLC
$12
Sumitomo Pharma America, Inc.
$1
Top 3 companies account for 49.9% of all-time payments
Associated products mentioned in payments ›
AIRSUPRA · ANORO · ANORO ELLIPTA · BASAGLAR · BELSOMRA · BREO · BREZTRI · BYSTOLIC · CAMZYOS · CHANTIX · CREON · Cologuard Collection Kit · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · ENTRESTO · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · FARXIGA · FREESTYLE LIBRE 2 · GEMTESA · GIMOTI · JANUVIA · JARDIANCE · LEQVIO · LINZESS · LYRICA · Livalo · MOUNJARO · NUPLAZID · Otezla · Ozempic · PAXLOVID · PRADAXA · PREMARIN · QULIPTA · Qdolo · REXULTI · Repatha · Rybelsus · STEGLATRO · STIOLTO RESPIMAT · SYNTHROID · TEKTURNA · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRULICITY · UBRELVY · VALTOCO · VERQUVO · VRAYLAR · Vascepa · Victoza · WATCHMAN Access System · Wegovy · XARELTO · XIFAXAN · XTAMPZA · Xofluza
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Family medicine - adults within 10 mi
3
Per 100K population
2.7
County median income
$60,614
Nearest hospital
SHARON REGIONAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. George is a clinical cardiology specialist, with above-average Medicare volume (top 18% in PA), with low-engagement industry engagement in the top 14% of PA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. George experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. George performed 267 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. George receive payments from pharmaceutical companies?
Yes. Dr. George received a total of $5,971 from 34 companies across 354 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. George's costs compare to other family medicine - adults in Sharon?
Dr. George's average Medicare payment per service is $51. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. George) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Family Medicine - Adults in Sharon
Browse family medicine - adults in Sharon ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine - Adults in PA
Family medicine - adults ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine - Adults in PA
Which PA family medicine - adults receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology